ArticleCancer reports (Hoboken, N.J.)2026

A Novel BRCA1 Pathogenic Variant in Tunisian Patient With High Grade Ovarian Cancer: Favorable Therapeutic Response to Olaparib.

Nihel Ammous-Boukhris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.